Related Experiment Video
Updated: Mar 22, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Oral mycoses and other opportunistic infections in HIV: therapy and emerging problems - a workshop report
K M Vidya1, U K Rao2, W Nittayananta3,4,5
1Department of Oral and Maxillofacial Pathology and Microbiology, Sathyabama University Dental College, Sathyabama University, Chennai, India.
Abstract:
Oral mycoses and other opportunistic infections are recognized features of HIV infection even after four decades of the epidemic. The therapeutic options, challenges of therapy, and evolving patterns of opportunistic infections were evaluated by the workshop. It was observed that high Candida counts and infection are still more prevalent in HIV-positive individuals even in the era of antiretroviral therapy. Furthermore, one or more non-Candida albicans are present in some HIV-positive individuals. While Candida species are more virulent in HIV infection, similar virulence may be present in other states of immunosuppression. Consequently, the interplay between host factors and virulence ultimately determines the clinical outcomes. Adverse clinical outcomes such as candidemia and other deep fungal infections are on the increase in HIV infection. Disseminated histoplasmosis and penicilliosis have been reported, especially with low CD4 counts. Even with advances in antifungal therapy, mortality and morbidity from deep fungal infections have not changed significantly. In addition, long-term exposure to common antifungal drugs such as fluconazole has led to the development of antifungal resistance in 6% to 36%. Development of new antifungal therapeutic agents and the use of alternative therapies may offer breakthrough. In addition, effective strategies to enhance the host immune status are being explored.
Insights
Opportunistic fungal infections, including high Candida counts, remain prevalent in individuals with HIV, even with antiretroviral therapy. Antifungal resistance and increased deep fungal infections pose significant challenges, necessitating new therapeutic strategies.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Immunology
Background:
- Opportunistic mycoses are common in Human Immunodeficiency Virus (HIV) infection.
- Antiretroviral therapy (ART) has altered but not eliminated these infections.
- Fungal infections like candidiasis, histoplasmosis, and penicilliosis persist in HIV patients.
Purpose of the Study:
- To evaluate therapeutic options and challenges for opportunistic infections in HIV.
- To assess evolving patterns of fungal infections in the context of ART.
- To highlight the increasing prevalence of Candida and non-Candida albicans in HIV-positive individuals.
Main Methods:
- Workshop evaluation of therapeutic options and infection patterns.
- Review of clinical data on fungal infections in HIV.
- Analysis of antifungal resistance trends.
Main Results:
- High Candida counts and infections remain prevalent in HIV patients despite ART.
- Non-Candida albicans species are identified in some HIV-positive individuals.
- Deep fungal infections (candidemia, histoplasmosis, penicilliosis) are increasing, with significant morbidity and mortality.
- Antifungal resistance rates range from 6% to 36% due to long-term drug exposure.
Conclusions:
- The interplay of host factors and fungal virulence dictates clinical outcomes in HIV.
- Advances in antifungal therapy have not significantly reduced mortality/morbidity from deep fungal infections.
- Development of novel antifungal agents, alternative therapies, and immune enhancement strategies are crucial.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Fungal Phylum Microsporidia
Retrovirus Life Cycles
Antifungal Agents
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

